학술논문

Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Document Type
Article
Source
In Journal of the American Academy of Dermatology December 2023
Subject
Language
ISSN
0190-9622